GENE ONLINE|News &
Opinion
Blog

2025-11-18|

Physicists Develop Non-Hermitian Systems Using 3D Chirality for Advanced Light Polarization Control

by GOAI
Share To

Physicists have introduced a new class of non-Hermitian systems that utilize three-dimensional (3D) chirality to achieve advanced control over light polarization. The study, recently published in *Light: Science & Applications*, demonstrates how these systems enable asymmetrical polarization switching and omni-polarizer functionality. Researchers highlight the potential applications of this discovery in optical technologies, marking a significant development in the field.

The findings focus on leveraging 3D chirality within non-Hermitian systems to manipulate light polarization with precision. The study outlines how these systems facilitate asymmetric polarization switching, allowing for directional control of polarized light. Additionally, the research describes an omni-polarizer capability, which enables uniform manipulation of all polarizations simultaneously. These advancements could pave the way for innovations in optical devices and communication technologies by providing enhanced control mechanisms for light behavior.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 18, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
QMSR Town Hall Discusses Integrating Risk Management into Product Design and Fostering Quality Culture in Pharma and Medical Devices
2026-01-16
LATEST
QMSR Town Hall Discusses Integrating Risk Management into Product Design and Fostering Quality Culture in Pharma and Medical Devices
2026-01-16
Magnesium Oxychloride Cement from Dolomite Ore Developed with Self-Cleaning Properties
2026-01-16
New Database MitoCommun Developed to Map Mitochondrial Communication Networks
2026-01-16
New Model Combines Computational Methods and Pharmacological Knowledge to Predict Adverse Drug Interactions
2026-01-16
Tolerance Bio Targets Congenital Athymia with Therapies to Restore Thymus Function
2026-01-16
United States to Implement International Pricing Benchmarks for Drug Costs by 2026
2026-01-16
JPMorgan’s Biotech Momentum and Asia’s Innovation Role Highlighted at Annual Industry Kickoff
2026-01-16
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top